Product Information
AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Micro Labs Limited, priced at $0.2626 per EA under NDC 42571023630. Its NADAC has been published 394 times since Dec 12, 2018.
Strength
10; 20 mg/1; mg/1
Manufacturer
Micro Labs LimitedNDC
42571023630
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207435On Market Since
1/1/2018
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 394 times since Dec 12, 2018, and over the history we have for it it has declined 56.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2626 per EA |
|---|---|
| All-time high | $0.9674 (Aug 14, 2019) |
| All-time low | $0.2626 (Jun 17, 2026) |
| 52-week high | $0.3713 |
| 52-week low | $0.2626 |
| Median price | $0.4213 |
| Average price | $0.4709 |
| Largest weekly change | +68.6% (Nov 22, 2023) |
| Weeks tracked | 394 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Micro Labs Limited, is $0.2626 per EA (NDC 42571023630), effective Jun 24, 2026.
How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 56.2%. It has been tracked across 394 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?
Since Dec 12, 2018, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2626 (Jun 17, 2026) to a high of $0.9674 (Aug 14, 2019), with a median of $0.4213 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?
5 NADAC-published products share the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 10-20 MG, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?
AMLODIPINE-OLMESARTAN 10-20 MG (NDC 42571023630) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification